Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/IMMUNOMEDICS-INC-9671/news/Immunomedics-Announces-Durable-Responses-in-Metastatic-Lung-Cancer-Patients-Treated-With-Sacituzumab-20475917/?utm_source=whatsapp&utm_medium=social&utm_campaign=share